President’s Research Fund (PRF)
The President’s Research Fund (PRF) supports projects that have a strong potential for obtaining external funding for SLU investigators. The funds are used to collect preliminary data for a new or related project, and also support cross-disciplinary projects to maximize collaborations across departments and schools at SLU.
Awards of up to $50,000 will be awarded, with a total amount of $125,000 allocated to the PRF in the School of Medicine for each cycle. Applications are accepted twice a year, in May and October, and are for a period of one calendar year. Information on changes to the funding deadlines and amounts can be viewed here: PRF Email.
For the Spring 2015 cycle, only full-time, tenure and non-tenure track faculty members in the School of Medicine may submit an application as PI or Co-PI. One application per deadline may be submitted. In accordance with the recent federal award policy change, previously unfunded PRF applications may be resubmitted an unlimited number of times.
To learn about the criteria used to evaluate internal proposals, please review our Internal Awards Peer Review Form.
- Two Annual Deadlines: October 31 and May 15
- Spring 2015 forms: PRF Guidelines, Application Package, and Subrecipient Form.
- The deadline for the Spring 2015 application cycle is Friday, May 15, 2015 at 5:00 p.m.
- Applications must be submitted through eRS.
- Questions? Contact Emily Beck in the Office of Research Development & Services (ORDS) at 977-7742 or via Email.
Award recipients for the Spring 2015 application cycle will be announced in early fall.
|Dale Dorsett, Ph.D.||Biochemistry & Molecular Biology||“Control of transcriptional enhancer function by mediator and cohesin”|
|David Ford, Ph.D.||Biochemistry & Molecular Biology||“Novel peptidoaldehyde mediators of inflammation derived from leukocyte myeloperoxidase activity”|
|Grant Kolar, M.D., Ph.D.||Pathology||“Complement opsonization of photoreceptor outer segments and binding by CR1 in the retinal pigmented epithelium”|
|Richard DiPaolo, Ph.D.||Molecular Microbiology and Immunology||“The role of IL-22 in promoting gastric cancer”|
|Jinsong Zhang, Ph.D.||Internal Medicine-Endocrinology||“Mitochondrial carbonic anhydrases and microvascular disease”|
|Debra H. Zand, Ph.D.||Pharmacological & Physiological Science||“Role of breast cancer anti-estrogen resistance protein BCAR2 in regulation of AIB1 transcription and estrogen receptor alpha signaling”|